Metabolites from Marine Sponges and Their Potential to Treat Malarial Protozoan Parasites Infection: A Systematic Review
- PMID: 33670878
- PMCID: PMC7997450
- DOI: 10.3390/md19030134
Metabolites from Marine Sponges and Their Potential to Treat Malarial Protozoan Parasites Infection: A Systematic Review
Abstract
Malaria is an infectious disease caused by protozoan parasites of the Plasmodium genus through the bite of female Anopheles mosquitoes, affecting 228 million people and causing 415 thousand deaths in 2018. Artemisinin-based combination therapies (ACTs) are the most recommended treatment for malaria; however, the emergence of multidrug resistance has unfortunately limited their effects and challenged the field. In this context, the ocean and its rich biodiversity have emerged as a very promising resource of bioactive compounds and secondary metabolites from different marine organisms. This systematic review of the literature focuses on the advances achieved in the search for new antimalarials from marine sponges, which are ancient organisms that developed defense mechanisms in a hostile environment. The principal inclusion criterion for analysis was articles with compounds with IC50 below 10 µM or 10 µg/mL against P. falciparum culture. The secondary metabolites identified include alkaloids, terpenoids, polyketides endoperoxides and glycosphingolipids. The structural features of active compounds selected in this review may be an interesting scaffold to inspire synthetic development of new antimalarials for selectively targeting parasite cell metabolism.
Keywords: Plasmodium; antimalarial; malaria; resistance; sponge.
Conflict of interest statement
The authors declare no conflict of interest.
Figures






Similar articles
-
Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.Int J Parasitol Drugs Drug Resist. 2015 Nov 28;6(1):1-11. doi: 10.1016/j.ijpddr.2015.11.003. eCollection 2016 Apr. Int J Parasitol Drugs Drug Resist. 2015. PMID: 26862473 Free PMC article.
-
A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.Microbiol Spectr. 2021 Oct 31;9(2):e0027421. doi: 10.1128/Spectrum.00274-21. Epub 2021 Sep 29. Microbiol Spectr. 2021. PMID: 34724729 Free PMC article.
-
THE EFFICACY OF MARINE NATURAL PRODUCTS AGAINST PLASMODIUM FALCIPARUM.J Parasitol. 2021 Mar 1;107(2):284-288. doi: 10.1645/20-93. J Parasitol. 2021. PMID: 33844839
-
Insight into molecular diagnosis for antimalarial drug resistance of Plasmodium falciparum parasites: A review.Acta Trop. 2023 May;241:106870. doi: 10.1016/j.actatropica.2023.106870. Epub 2023 Feb 26. Acta Trop. 2023. PMID: 36849091 Review.
-
New dimensions in the field of antimalarial research against malaria resurgence.Eur J Med Chem. 2019 Nov 1;181:111353. doi: 10.1016/j.ejmech.2019.05.043. Epub 2019 Jun 24. Eur J Med Chem. 2019. PMID: 31525705 Review.
Cited by
-
A Review of Sponge-Derived Diterpenes: 2009-2022.Mar Drugs. 2024 Sep 28;22(10):447. doi: 10.3390/md22100447. Mar Drugs. 2024. PMID: 39452855 Free PMC article. Review.
-
Marine Pharmacology in 2019-2021: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis and Antiviral Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action.Mar Drugs. 2024 Jun 30;22(7):309. doi: 10.3390/md22070309. Mar Drugs. 2024. PMID: 39057418 Free PMC article. Review.
-
Development and Comparison of Two 3D-Printed Scaffolds of Biosilica from Marine Sponges for Bone Tissue Engineering.ACS Omega. 2025 May 15;10(20):20257-20267. doi: 10.1021/acsomega.4c11383. eCollection 2025 May 27. ACS Omega. 2025. PMID: 40454048 Free PMC article.
-
Emerging Molecular Mechanisms in Malaria Pathogenesis and Novel Therapeutic Approaches: A Focus on P. falciparum Malaria.Biomolecules. 2025 Jul 17;15(7):1038. doi: 10.3390/biom15071038. Biomolecules. 2025. PMID: 40723909 Free PMC article. Review.
References
-
- Crompton P.D., Moebius J., Portugal S., Waisberg M., Hart G., Garver L.S., Miller L.H., Barillas C., Pierce S.K. Malaria immunity in man and mosquito: Insights into unsolved mysteries of a deadly infectious disease. Annu. Rev. Immunol. 2014;32:157–187. doi: 10.1146/annurev-immunol-032713-120220. - DOI - PMC - PubMed
-
- World Health Organization . WHO Malaria Report 2017. World Health Organization; Geneva, Switzerland: 2017.
-
- Bridgford J.L., Xie S.C., Cobbold S.A., Pasaje C.F.A., Herrmann S., Yang T., Gillett D.L., Dick L.R., Ralph S.A., Dogovski C., et al. Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome. Nat. Commun. 2018;9:1–9. doi: 10.1038/s41467-018-06221-1. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources